MedPath

Selective Internal Radiotherapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Cholangiocellular Carcinoma (CCC).

Phase 2
Conditions
Intrahepatic Cholangiocellular Carcinoma
Interventions
Procedure: SIRT
Procedure: DEB TACE
Registration Number
NCT01798147
Lead Sponsor
Johannes Gutenberg University Mainz
Brief Summary

Selective Internal Radiotherapy is superior to Transarterial Chemoembolisation for the treatment of intrahepatic cholangiocellular carcinoma (CCC).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
24
Inclusion Criteria
  • ≥18 years
  • Intrahepatic CCC, proven by histology or by typical morphology in cross sectional imaging and elevated tumor markers (CEA or CA 19-9)
  • Tumor confined to the liver
  • At least one measurable lesion in magnetic resonance imaging (MRI)
  • Tumor load ≤ 50%
  • Preserved liver function (Child Pugh A and B)
  • ECOG performance status ≤2
Exclusion Criteria
  • Patients feasible for curative treatment (e.g. resection or local ablation)
  • Previous TACE or SIRT
  • Prior Chemotherapy
  • Child Pugh stage C
  • ECOG Performance Status >1
  • Tumor involvement >50% of the liver
  • Extrahepatic tumor
  • Serum Bilirubin >2.0 mg/dl; Serum Albumin 2.8 g/dl, Serum Creatinine >2 mg/dl; Leukocytes <3000/ml; Thrombocytes <50000/ml
  • Clinically apparent ascites (ascites only in CT/MRI is no exclusion criteria)
  • Esophageal bleeding during the last 3 months
  • Hepatic encephalopathy
  • Transjugular intrahepatic portosystemic shunt (TIPS)
  • Infiltration or occlusion of the main portal vein
  • Hepatofugal blood flow in the portal vein
  • Hepatopulmonary shunt ≥ 20% in the macroaggregated albumin scan (MAA-scan)
  • Contraindications against angiography
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SIRTSIRTSelective Internal Radiotherapy using Yttrium 90 loaded resin beads (Sir Spheres)
DEB TACEDEB TACEDrug eluting Beads (DC Beads) loaded with Doxorubicin
Primary Outcome Measures
NameTimeMethod
Progression-free survival (PFS)at the end of study
Secondary Outcome Measures
NameTimeMethod
Overall survival (OS)at the end of study
Time to progression (TTP)at the end of study

Trial Locations

Locations (1)

Department of Diagnostic and Interventional Radiology

🇩🇪

Mainz, Germany

© Copyright 2025. All Rights Reserved by MedPath